DHX16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.024000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.369600E-01
Normal-vs-Stage2
2.183400E-01
Normal-vs-Stage3
9.024400E-02
Normal-vs-Stage4
7.722800E-01
Stage1-vs-Stage2
6.319400E-01
Stage1-vs-Stage3
8.970000E-02
Stage1-vs-Stage4
1.407830E-01
Stage2-vs-Stage3
3.002400E-02
Stage2-vs-Stage4
3.958800E-01
Stage3-vs-Stage4
1.161940E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.335000E-01
Normal-vs-AfricanAmerican
4.385600E-01
Normal-vs-Asian
1.922370E-01
Caucasian-vs-AfricanAmerican
7.117600E-01
Caucasian-vs-Asian
6.944400E-01
AfricanAmerican-vs-Asian
9.264800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.831200E-01
Normal-vs-Female
1.354850E-01
Male-vs-Female
4.051200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.875600E-01
Normal-vs-Age(41-60Yrs)
5.181800E-01
Normal-vs-Age(61-80Yrs)
2.285600E-01
Normal-vs-Age(81-100Yrs)
5.532200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.640200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.304200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.865200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.125400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.381000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.030400E-01
Normal-vs-Daily Drinker
7.726400E-02
Normal-vs-Weekly Drinker
4.005800E-01
Normal-vs-Occasional Drinker
7.101600E-01
Normal-vs-Social Drinker
4.907000E-01
Non Drinker-vs-Daily Drinker
2.100800E-01
Non Drinker-vs-Weekly Drinker
5.280600E-01
Non Drinker-vs-Occasional Drinker
6.008000E-02
Non Drinker-vs-Social Drinker
8.496400E-01
Daily Drinker-vs-Weekly Drinker
1.069760E-01
Daily Drinker-vs-Occasional Drinker
4.863800E-03
Daily Drinker-vs-Social Drinker
1.620190E-01
Weekly Drinker-vs-Occasional Drinker
3.158800E-01
Weekly Drinker-vs-Social Drinker
6.292400E-01
Occasional Drinker-vs-Social Drinker
8.891700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.748400E-01
Normal-vs-Grade 2
5.905800E-01
Normal-vs-Grade 3
5.717000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.618400E-01
Grade 1-vs-Grade 3
2.659000E-01
Grade 1-vs-Grade 4
2.748400E-01
Grade 2-vs-Grade 3
6.508400E-01
Grade 2-vs-Grade 4
5.905800E-01
Grade 3-vs-Grade 4
5.717000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.233600E-01
Normal-vs-NonDiabetic
1.383180E-01
Diabetic-vs-NonDiabetic
8.297400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.935180E-01
Normal-vs-NoPancreatitis
1.769790E-01
Pancreatitis-vs-NoPancreatitis
9.311600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.265400E-01
Normal-vs-N1
1.981800E-01
N0-vs-N1
3.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.100800E-01
Normal-vs-TP53-NonMutant
4.972400E-01
TP53-Mutant-vs-TP53-NonMutant
9.527600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
